This independent LC-MS lab test confirms FOX04-DRI 10mg from BioLongevity Labs at 99.76% purity. The analysis was conducted by MDx BioAnalytical Laboratory on April 9, 2026.
FOX04-DRI is a peptide researched for its potential role in senescent cell clearance, cellular rejuvenation, and aging-related health support. A purity level of 99.76% indicates minimal contamination and high-grade synthesis. Endotoxin testing passed at ≤0.05 EU/mL, confirming safety for research applications.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.